A real world study assessing the clinical characteristics and effect of antifibrotic treatment in patients with Interstitial Pneumonia with Autoimmune Features
Latest Information Update: 04 Jul 2020
At a glance
- Drugs Nintedanib (Primary) ; Pirfenidone (Primary) ; Steroids
- Indications Interstitial lung diseases
- Focus Therapeutic Use
Most Recent Events
- 04 Jul 2020 New trial record
- 20 May 2020 Results presented at the 116th International Conference of the American Thoracic Society